CATALENT PHARMA SOLUTIONS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at CATALENT PHARMA SOLUTIONS is $94,189, based on 387 certified filings from FY 2020 to FY 2026. This is 22% lower than the national H-1B median salary of $120,000. Compensation at CATALENT PHARMA SOLUTIONS reflects their market positioning, with entry-level roles starting around $75,000 and senior positions reaching $139,847 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at CATALENT PHARMA SOLUTIONS range from $56,277 at the 10th percentile to $139,847 at the 90th percentile, showing a $83,570 spread across experience levels and roles. The 25th percentile is $75,000 and the 75th percentile is $116,459.

Yes, CATALENT PHARMA SOLUTIONS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), CATALENT PHARMA SOLUTIONS filed 44 H-1B labor condition applications with 42 certified and 0 denied, at a median salary of $80,700. Across FY 2020–2026, they have filed 423 total H-1B applications with 387 certified and a 0.2% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. CATALENT PHARMA SOLUTIONS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), CATALENT PHARMA SOLUTIONS filed 44 H-1B applications, with 42 certified and 0 denied. Over 7 years of data, CATALENT PHARMA SOLUTIONS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

CATALENT PHARMA SOLUTIONS's LCA (Labor Condition Application) denial rate is 0.2%, with 1 out of 423 applications denied across all years. This translates to a 99.8% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating CATALENT PHARMA SOLUTIONS as a potential H-1B sponsor.

This is an excellent approval rate, indicating CATALENT PHARMA SOLUTIONS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

CATALENT PHARMA SOLUTIONS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 387 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles CATALENT PHARMA SOLUTIONS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at CATALENT PHARMA SOLUTIONS:

The most frequently sponsored role is Research Scientist with 40 filings at a median salary of $87,141. This is followed by Senior Research Scientist (35 filings) and Technician, Biomanufacturing, Downstream/Mrna.

CATALENT PHARMA SOLUTIONS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where CATALENT PHARMA SOLUTIONS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top CATALENT PHARMA SOLUTIONS H-1B locations:

The largest H-1B hub for CATALENT PHARMA SOLUTIONS is Madison, WI with 118 filings at a median salary of $68,000. The highest-paying location is Chelsea, MA at $130,000 median. Salaries range from $68,000 to $130,000 across office locations.

CATALENT PHARMA SOLUTIONS's median H-1B salary has increased by +1% from FY 2020 ($80,000) to FY 2026 ($80,700). Tracking salary trends over time reveals how CATALENT PHARMA SOLUTIONS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at CATALENT PHARMA SOLUTIONS.

Year-by-year breakdown:

• FY 2022: $100,000 (59 certified)
• FY 2023: $95,000 (45 certified)
• FY 2024: $100,000 (48 certified)
• FY 2025: $100,000 (78 certified)
• FY 2026: $80,700 (42 certified)

CATALENT PHARMA SOLUTIONS has maintained steady salary growth for H-1B positions over this period.

CATALENT PHARMA SOLUTIONS primarily files H-1B applications at Wage Level IV, accounting for 37% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making CATALENT PHARMA SOLUTIONS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 84% of positions at Level II or higher, CATALENT PHARMA SOLUTIONS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

CATALENT PHARMA SOLUTIONS's median H-1B salary of $94,189 is 22% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating CATALENT PHARMA SOLUTIONS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare CATALENT PHARMA SOLUTIONS's offerings with similar companies in your field for a more accurate assessment.

CATALENT PHARMA SOLUTIONS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. CATALENT PHARMA SOLUTIONS's higher proportion of Level III-IV positions (57%) may benefit from wage-based lottery prioritization.

With 387 certified filings, CATALENT PHARMA SOLUTIONS invests significantly in H-1B sponsorship. The company's 0.2% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.